Ethel Weld

Medicine & Life Sciences

1. GSK1265744 100%
2. HIV 93%
3. Pharmacokinetics 46%
4. Pre-Exposure Prophylaxis 35%
5. HIV Infections 30%
6. Tuberculosis 30%
7. Rilpivirine 28%
8. Multidrug-Resistant Tuberculosis 28%
9. IQP-0528 25%
10. Gels 25%
11. Safety 24%
12. Injections 23%
13. Hormonal Contraception 20%
14. Universal Design 19%
15. Pharmaceutical Preparations 18%
16. Population 16%
17. Multiparametric Magnetic Resonance Imaging 16%
18. Shigella flexneri 16%
19. Therapeutic Human Experimentation 15%
20. Lubricants 15%
21. Neglected Diseases 15%
22. Therapeutics 15%
23. Donor Selection 15%
24. Severe Acute Respiratory Syndrome 15%
25. Enema 14%
26. Coronavirus 14%
27. Shigella 14%
28. Anti-Infective Agents 14%
29. Child 14%
30. Viral Load 13%
31. Climate 13%
32. Intramuscular Injections 13%
33. Rifampin 12%
34. Hepatitis C 11%
35. Ethics 11%
36. Breast Feeding 11%
37. Microbiota 11%
38. cellulose acetate-butyrate 11%
39. HIV-1 11%
40. Immunoglobulin A 10%
41. Hepacivirus 10%
42. Colon 10%
43. Epidemics 10%
44. Volunteers 9%
45. anti-IgA 9%
46. Oral Contraceptives 9%
47. Therapeutic Uses 9%
48. Clinical Trials 9%
49. Interleukin-6 8%